DKK3 and lobular neoplasia: In fact, during the 3-year follow-up, 27% of the LN patients exhibited a decrease in eGFR and an upstaging in the KDIGO classification of CKD, and this LN subpopulation exhibiting disease progression also presented with increased DKK3 serum levels at baseline.